Newsletters

LabNotes


LabNotes - Volume 17, No. 1, 2006

Industry News

BD (Becton, Dickinson and Company) (NYSE: BDX) has announced the purchase of Burlington, NC-based TriPath Imaging (Nasdaq: TPTH), makers of an automated diagnostic test for cervical cancer screening (Pap smear). TriPath develops and markets innovative solutions for the clinical management of cancer, including detection, diagnosis, staging, and treatment. As cancer remains a leading worldwide health concern, this acquisition expands the BD scope of expertise in the areas of cancer diagnostics, disease state management, and next-generation medical technologies.

 sidebar

  IN THIS ISSUE

From the Editor

FEATURE
Preanalytical Errors in the Emergency Department
.

Differences in Composition of Capillary and Venous Blood Specimen
.

New Information About Safety

Industry News
BD has announced the purchase of Burlington, NC-based TriPath Imaging

Product News
New Tube Coming Soon

Introducing BD Microtainer® Contact-Activated Lancet

CLMA Scholarship Opportunuties

See us at CLMA
.

BD Values your opinion...Take the LabNotes on-line survey

.

Urine Test Survey Results

Web-Based Seminars

BD Vacutainer® Brand and Trademark

Subscribe

Download this issuePDF

View previous issues


For questions regarding our Blood, Urine collection, or other sample collection products and services please contact us.

This publication is a service to the customers and friends of BD, and is designed only to provide general information. It is not intended to be comprehensive or provide any legal or medical advice.